DRKS00028865已完成未知
Serial antibody progression after 3rd dose of vaccination in thoracic organ transplant patients with inadequate immune response after dual protective vaccination against SARS-CoV-2 coronavirus - H/LTX-Cov19-3. Dosis
Herz- und Diabeteszentrum NRW, Klinik für Thorax-und Kardiovaskularchirurgie0 个研究点目标入组 390 人开始时间: 2022年4月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 390
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Men and women after thoracic organ transplantation (heart, lung, combined heart-lung) with a minimum age of 18 years who have received a first and second vaccination against SARS-CoV-2.
- •Precondition: Present signed and dated study consent.
排除标准
- •Acute infections;
- •Medical complications that could increase the risk of vaccination in the opinion of the clinicians treating the patient and/or the physicians responsible for the study, in particular
- •o Rejection reactions in the past 3 months with the need for augmentation of standard.
研究者
相似试验
招募中
不适用
Pattern of antibody response after 3rd dose of COVID-19 vaccine booster among healthy volunteers.Healthy volunteerCOVID-19 Vaccinesadministration and dosageimmunologyTCTR20210831002akornping Hospital180
招募中
不适用
Pattern of antibody response after 4th dose of COVID-19 vaccine booster among healthy volunteershealthy volunteersCOVID-19 Vaccines administration and dosage immunologyTCTR20220217001akornping hospital180
进行中（未招募）
不适用
Persistence of antibodies at 3, 4 and 6 years of age after vaccination with meningococcal, pneumococcal and Hib vaccinesHealthy volunteers (prevention of invasive diseases caused by Haemophilus influenzae (type b) and Neisseria meningitidis serogroup C)MedDRA version: 14.1Level: LLTClassification code 10027275Term: Meningococcal infection, unspecifiedSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10069533Term: Haemophilus influenzae type b immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2008-007846-69-DEGlaxoSmithKline Biologicals581
招募中
不适用
Immune response to the 3rd dose booster with mRNA-1273 COVID-19 vaccine in individuals who had received 2 doses of CoronaVac or ChAdOx-1 COVID-19 vaccineTCTR20211115003Thammasat University Hospital100
已完成
3 期
Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationDiphtheriaPoliomyelitisHaemophilus Influenzae Type bHepatitis BTetanusWhooping CoughNCT01983540Sanofi Pasteur, a Sanofi Company558